First Trial in US Exploring Ivermectin Against COVID-19 Begins

A scanning electron microscope image with the CCP virus (orange) isolated from a patient in the United States, emerging from the surface of cells (green) cultured in a lab. NIAID-RML/CC BY 2.0

A new clinical trial recently started testing three drugs against COVID-19, along with the widely used hydroxychloroquine.

Scientists at the University of Kentucky’s College of Medicine said they'll investigate the effectiveness of azithromycin, ivermectin, and camostat mesylate—drugs that could inhibit the replication of SARS-CoV-2, the CCP virus.